Cleared Traditional

K252043 - Bipolar applicator CelonProBreath (WB99...

Also marketed or referenced as:
Bipolar applicator CelonProSleep plus (WB990311) Bipolar applicator CelonProBreath (WB990210) Bipolar applicator CelonProSleep plus (WB990211)

K252043 is the FDA 510(k) clearance for Bipolar applicator CelonProBreath (WB99... by Olympus Winter & Ibe GmbH. It is a Class 2 Ear, Nose, Throat device (product code GEI) cleared through the Traditional 510(k) pathway after a 85-day FDA review.

K252043 · Olympus Winter & Ibe GmbH · Ear, Nose, Throat device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2025
Decision
85d
Days
Class 2
Risk

K252043 is an FDA 510(k) clearance for the Bipolar applicator CelonProBreath (WB990310). Classified as Electrosurgical, Cutting & Coagulation & Accessories within the GEI classification (a category for electrosurgical cutting and coagulation devices), Class II - Special Controls.

Submitted by Olympus Winter & Ibe GmbH (Hamburg, DE). The FDA issued a Cleared decision on September 23, 2025 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 878.4400 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Olympus Winter & Ibe GmbH devices

Submission Details

510(k) Number K252043 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2025
Decision Date September 23, 2025
Days to Decision 85 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 89d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEI Electrosurgical, Cutting & Coagulation & Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ear, Nose, Throat devices follow this clearance model.

Regulatory Consultant

Olympus Surgical Technologies America
Teffany Hutto

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - GEI Electrosurgical, Cutting & Coagulation & Accessories

All 1118
Devices cleared under the same product code (GEI) and FDA review panel - the closest regulatory comparables to K252043.
Ultrasonic Bipolar Generator (USG-410)
K252150 · Olympus Medical Systems Corporation · Oct 2025
E Blator
K251899 · New Deantronics Taiwan , Ltd. · Oct 2025
NEW DOUBLO 2.0
K251334 · Hironic Co., Ltd. · Sep 2025
Legend X Platform
K252576 · Pollogen, Ltd. · Sep 2025
PhotonBlade 3
K250483 · Stryker Instruments · Sep 2025
AGNES Ultra
K250217 · Agnes Medical Co., Ltd. · Sep 2025